Latest Capital Raising News

Macarthur Minerals (ASX:MIO) has clarified the timing of its cleansing notice relative to a key Programme of Work approval, affirming compliance with ASX continuous disclosure rules and explaining the rationale behind delayed disclosure.

Oneview Healthcare has secured A$12.3 million from its placement and security purchase plan, though the SPP fell well short of its A$2 million target. The company will now seek shareholder approval for the final tranche of its A$19 million raise at the September AGM.

McLaren Minerals has announced a fully underwritten Share Purchase Plan targeting A$1.5 million at a 15.5% discount, offering eligible shareholders free attaching options. The capital will support feasibility studies and exploration at its key projects.

Accordant Group Limited’s shareholders have approved a significant share issuance under a Rights Offer, allowing the Hull Family Trust to increase its voting control beyond 20%. The move also greenlights additional share allocations to related parties to cover subscription shortfalls.

HITIQ Limited has drawn down a $1 million loan from a major shareholder associate, with plans to convert the debt into convertible notes subject to shareholder approval. The initial tranche aims to bolster working capital amid ongoing capital market challenges.

Taiton Resources has raised $1.25 million through a discounted placement to accelerate drilling at its Highway Copper-Gold Project, including immediate work on the high-priority Yogi IOCG target, alongside exploration at Challenger West and technical studies at Kingsgate.

Carbonxt Group has secured $750,000 through convertible notes from major shareholder Phelbe Pty Ltd, targeting expansion of its Minnesota pellet manufacturing and increasing its New Carbon Processing stake to 48.1%.

Livium has extended its recycling agreement with Sell & Parker by a year, secured an upfront deposit, and is ramping up processing volumes with a new dedicated plant at Campbellfield.

Neurizon Therapeutics has secured an additional A$2.7 million through a placement addressing the shortfall from its entitlement offer, lifting total proceeds to approximately A$8.5 million. This fresh capital strengthens the biotech’s balance sheet and provides financial flexibility as it advances its lead ALS drug NUZ-001 through pivotal clinical stages.

BlinkLab has secured A$17.5 million through an oversubscribed placement to fuel regulatory trials and commercial launch of its AI-driven autism and ADHD diagnostic tools.

Nutritional Growth Solutions has appointed director Manik Pujara as interim CEO and CFO, replacing Andrew Grover who remains as nonexecutive chair. This leadership shuffle coincides with ongoing exploration of corporate opportunities.

Midas Minerals has raised $28 million through a heavily supported placement to fund expanded drilling and feasibility studies at its Otavi project in Namibia. The capital boost lifts the company’s cash reserves to approximately $33 million, underpinning an aggressive exploration push.